Transfection Efficiency in Primary Cells vs. Immortalized Cell Lines: Technical Barriers and Solutions

Transfecting primary cells presents significantly greater challenges than working with immortalized cell lines due to inherent biological and physiological differences. Primary cells, which are freshly isolated from tissues and maintain many characteristics of in vivo cells, tend to be more sensitive, less proliferative, and possess robust defense mechanisms against foreign nucleic acids, all of which can hinder DNA delivery and expression.

One major barrier is the reduced rate of endocytosis and membrane fluidity in primary cells, which impairs uptake of DNA complexes formed by chemical transfection agents. Unlike immortalized cell lines, primary cells often have lower expression of receptors or transporters that facilitate endocytosis, reducing internalization efficiency. Additionally, primary cells are more prone to cytotoxicity induced by transfection reagents, requiring careful titration of reagent-to-DNA ratios to minimize cell death.

Nuclear import is another limiting factor. Many primary cells divide slowly or are quiescent, limiting the passive entry of plasmid DNA during mitosis. Therefore, efficient nuclear targeting strategies, such as the use of nuclear localization signals or advanced carrier systems, are critical for successful transgene expression.

Electroporation and nucleofection have emerged as preferred techniques for primary cells, allowing direct delivery of DNA into the cytoplasm or nucleus by temporarily permeabilizing the plasma membrane. However, these physical methods require precise optimization of electrical parameters to balance transfection efficiency and cell viability, as excessive voltage or pulse length can induce irreversible damage.

Moreover, serum proteins and extracellular matrix components present in primary cell cultures can interfere with chemical transfection reagents by causing aggregation or reducing complex stability. Serum-free or specially formulated media are often used during transfection to mitigate these effects.

Advances in nanoparticle-based delivery systems incorporating targeting ligands or stimuli-responsive materials offer promising avenues to enhance transfection efficiency in primary cells. These novel carriers can exploit receptor-mediated endocytosis pathways specific to primary cell types, promoting uptake and intracellular trafficking.

In summary, transfection of primary cells requires tailored strategies that address their unique biological features. Combining optimized physical or chemical delivery methods with protective formulations and nuclear targeting enhances transgene delivery and expression while preserving cell viability and function.